Avoid Additive Painkillers. See DRX9000 and ISCS.
Teens who are given prescription narcotic painkillers may run a higher risk of abusing narcotics after high school, a new study suggests.
Researchers said teen painkiller use was associated with a 33 percent increased risk of later abuse. And it was seen mostly among those with little to no history of drug use and those who strongly disapproved of illegal drug use.
"A prescription for a pain reliever can put adolescents at risk for future pain reliever misuse," said study author Richard Miech, a research professor at the Survey Research Center at the University of Michigan in Ann Arbor.
For the study, Miech and his colleagues used data that tracked more than 6,200 high school seniors until they were 23.
At first glance, it seems counterintuitive that the increased risk was concentrated among teens who had little experience with illegal drugs, Miech acknowledged.
"This finding may be explained in part by the novelty of drug use effects," he said. For teens with little to no drug history, a prescription narcotic painkiller is likely to be their first experience with an addictive substance, Miech explained.
"Most likely, the initial experience of pain relief is pleasurable and a safe initial experience may reduce perceived danger," he said. "A pleasurable and safe initial experience with a drug is a central factor in theories of who goes on to misuse drugs."
In contrast, among teens with more extensive experience with drugs, the legitimate use of a narcotic pain reliever may make relatively less of an impression in comparison to the other drugs they have used, Miech said.
"Although these experienced individuals may go on to misuse prescription pain relievers, such misuse does not appear to result from an introduction to pain relievers through a legitimate prescription," he said.
The findings are especially timely in light of the recent decision by the U.S. Food and Drug Administration to approve the use of the narcotic painkiller OxyContin for children ages 11 to 16, he said.
"These findings suggest a currently unrecognized risk of narcotic prescribing," Miech said. "This risk should be incorporated into prescribing decisions and patient counseling."
Integrity Life Sciences delivers a multitude of orthotic treatment options to address one of the most costly systemic ailments in the world, chronic low back and neck pain. Our advanced solution begins with the Integrity Spinal Care System (ISCS) ™ and its proprietary iELCiPS Technology™. The ISCS non-surgical spinal decompression modality systems are engineered to provide pain relief for compressive and degenerative conditions of the spine. Specifically, conditions that may be treated include: neck pain and back pain associated with herniated discs, protruding discs, degenerative disc disease, posterior facet syndrome, and sciatica. It achieves these effects through decompression of intervertebral discs, that is, unloading due to distraction and positioning.
As a compliment to the ISCS, Integrity offers the very effective Integrity Gel Support Brace™. Our advanced lumbar support brace is a fitting compliment to non-surgical spinal decompression therapy and was designed as an adjunct therapy for those suffering from back pain due to disc related conditions. The Integrity Gel Support Brace may be used with or without Integrity’s non-surgical spinal decompression systems and is an excellent treatment option for the patient to use at home.
In addition, Integrity Life Sciences has been exclusively granted the use of all of the technology, products, US Patent and Trademark Office’s assignments, logos and other forms of intellectual property that were created by Axiom Worldwide, INC under the leadership of Jim Gibson from Tampa, Florida. The agreement specifically includes the flagship product DRX 9000™, its family of products, and all of its derivatives such as the DRX9000C. Integrity offers support for these products, which includes: sales, maintenance services, and repairs. Only Integrity Life Sciences is Registered with the US FDA as a Factory Authorized – Contract Manufacturer – for Axiom Worldwide and the DRX9000 True Non-Surgical Spinal Decompression Systems™
James Gibson, President of Integrity Life Sciences and Axiom Worldwide states “Our partners, in over 50 countries and territories, have the unique opportunity to present a cutting edge medical device, utilizing a clinically validated protocol that restores a patient’s quality of life non-surgically and without pharmaceutical or invasive intervention“. With a body of published clinical research from around the world will support and strengthen your sales presentation; members of our medical advisory board herald from prestigious institutions such as Johns-Hopkins and The Mayo Clinic just to name a few. In addition, partners will have confidence in a quality product that adheres to the stringent standards mandated by FDA, CE, and ISO. Sales, marketing, and technical training is offered in prestigious locations in Europe, Asia, the Middle East and throughout the United States.
Learn more @: www.IntegrityLifeSciences.
Integrity Life Sciences, LLC and Axiom Worldwide, INC are privately held companies with global interests and shareholders with international partners located across the globe with a mission of “Restoring Integrity to the Spine™” and delivering "True Non-Surgical Spinal Decompression"
For additional information please visit: www.
Elements as Published in: Get Healthy
No comments:
Post a Comment